Drug profile · INN
fluphenazine decanoate
FLUPHENAZINE DECANOATE
fluphenazine decanoate (FLUPHENAZINE DECANOATE) is a dopamine d2 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — fluphenazine decanoate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
fluphenazine decanoate (FLUPHENAZINE DECANOATE) is a dopamine d2 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Dopamine D2 receptor antagonist
Primary target: D(2) dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fluphenazine decanoate?
fluphenazine decanoate (FLUPHENAZINE DECANOATE) is a dopamine d2 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for fluphenazine decanoate?
FLUPHENAZINE DECANOATE is a marketed brand name for fluphenazine decanoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fluphenazine decanoate?
fluphenazine decanoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.